{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:14:09Z","timestamp":1791846849280,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Suomen Akatemia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"City of Oulu"},{"DOI":"10.13039\/501100008415","name":"Diabetesliitto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004037","name":"Juho Vainion S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008487","name":"Sosiaali- ja Terveysministeri\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008487","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00125-018-4590-6","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T06:32:50Z","timestamp":1521786770000},"page":"1424-1434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["Ceramide stearic to palmitic acid ratio predicts incident diabetes"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0663-5843","authenticated-orcid":false,"given":"Mika","family":"Hilvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuire","family":"Salonurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki S.","family":"Havulinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimple","family":"Kauhanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Ringdal","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grethe S.","family":"Tell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Teeriniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Laatikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Jousilahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku J.","family":"Savolainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottar","family":"Nyg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veikko","family":"Salomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reijo","family":"Laaksonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"4590_CR1","volume-title":"Global report on diabetes","author":"World Health Organization","year":"2016","unstructured":"World Health Organization (2016) Global report on diabetes. World Health Organization, Geneva"},{"key":"4590_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes JM, Cooper ME (2013) Mechanisms of diabetic complications. Physiol Rev 93:137\u2013188","journal-title":"Physiol Rev"},{"key":"4590_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4239\/wjd.v6.i2.296","volume":"6","author":"N Bansal","year":"2015","unstructured":"Bansal N (2015) Prediabetes diagnosis and treatment: a review. World J Diabetes 6:296\u2013303","journal-title":"World J Diabetes"},{"key":"4590_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.cmet.2012.04.002","volume":"15","author":"JA Chavez","year":"2012","unstructured":"Chavez JA, Summers SA (2012) A ceramide-centric view of insulin resistance. Cell Metab 15:585\u2013594","journal-title":"Cell Metab"},{"key":"4590_CR5","doi-asserted-by":"publisher","first-page":"E1841","DOI":"10.3390\/ijms17111841","volume":"17","author":"DF Markgraf","year":"2016","unstructured":"Markgraf DF, Al-Hasani H, Lehr S (2016) Lipidomics\u2013reshaping the analysis and perception of type 2 diabetes. Int J Mol Sci 17:E1841","journal-title":"Int J Mol Sci"},{"key":"4590_CR6","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.celrep.2017.02.019","volume":"18","author":"L Wigger","year":"2017","unstructured":"Wigger L, Cruciani-Guglielmacci C, Nicolas A et al (2017) Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans. Cell Rep 18:2269\u20132279","journal-title":"Cell Rep"},{"key":"4590_CR7","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","volume":"37","author":"R Laaksonen","year":"2016","unstructured":"Laaksonen R, Ekroos K, Sysi-Aho M et al (2016) Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur Heart J 37:1967\u20131976","journal-title":"Eur Heart J"},{"key":"4590_CR8","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1161\/ATVBAHA.116.307497","volume":"36","author":"AS Havulinna","year":"2016","unstructured":"Havulinna AS, Sysi-Aho M, Hilvo M et al (2016) Circulating ceramides predict cardiovascular outcomes in the population-based FINRISK 2002 cohort. Arterioscler Thromb Vasc Biol 36:2424\u20132430","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4590_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/eurpub\/cku174","volume":"25","author":"K Borodulin","year":"2015","unstructured":"Borodulin K, Vartiainen E, Peltonen M et al (2015) Forty-year trends in cardiovascular risk factors in Finland. Eur J Pub Health 25:539\u2013546","journal-title":"Eur J Pub Health"},{"key":"4590_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010100","volume":"5","author":"V Salomaa","year":"2010","unstructured":"Salomaa V, Havulinna A, Saarela O et al (2010) Thirty-one novel biomarkers as predictors for clinically incident diabetes. PLoS One 5:e10100","journal-title":"PLoS One"},{"key":"4590_CR11","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1161\/ATVBAHA.113.301714","volume":"33","author":"GF Tveitevag Svingen","year":"2013","unstructured":"Tveitevag Svingen GF, Ueland PM, Pedersen EKR et al (2013) Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris. Arterioscler Thromb Vasc Biol 33:2041\u20132048","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4590_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/jama.300.7.795","volume":"300","author":"M Ebbing","year":"2008","unstructured":"Ebbing M, Bleie \u00d8, Ueland PM et al (2008) Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography. JAMA 300:795\u2013804","journal-title":"JAMA"},{"key":"4590_CR13","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1007\/s00125-017-4329-9","volume":"60","author":"EW Rebnord","year":"2017","unstructured":"Rebnord EW, Strand E, Midttun \u00d8 et al (2017) The kynurenine:tryptophan ratio as a predictor of incident type 2 diabetes mellitus in individuals with coronary artery disease. Diabetologia 60:1712\u20131721","journal-title":"Diabetologia"},{"key":"4590_CR14","unstructured":"World Health Organization (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. \n                    www.who.int\/diabetes\/publications\/report-hba1c_2011.pdf\n                    \n                  . Accessed 20 October 2017"},{"key":"4590_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijmedinf.2016.02.005","volume":"96","author":"P Karppinen","year":"2016","unstructured":"Karppinen P, Oinas-Kukkonen H, Alah\u00e4iv\u00e4l\u00e4 T et al (2016) Persuasive user experiences of a health behavior change support system: a 12-month study for prevention of metabolic syndrome. Int J Med Inform 96:51\u201361","journal-title":"Int J Med Inform"},{"key":"4590_CR16","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1007\/s00216-016-9425-z","volume":"408","author":"D Kauhanen","year":"2016","unstructured":"Kauhanen D, Sysi-Aho M, Koistinen KM, Laaksonen R, Sinisalo J, Ekroos K (2016) Development and validation of a high-throughput LC-MS\/MS assay for routine measurement of molecular ceramides. Anal Bioanal Chem 408:3475\u20133483","journal-title":"Anal Bioanal Chem"},{"key":"4590_CR17","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1081\/STA-200026579","volume":"33","author":"L Antolini","year":"2004","unstructured":"Antolini L, Nam B-H, D\u2019Agostino RB (2004) Inference on correlated discrimination measures in survival analysis: a nonparametric approach. Commun Stat Theory Methods 33:2117\u20132135","journal-title":"Commun Stat Theory Methods"},{"key":"4590_CR18","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2017","unstructured":"Core Team R (2017) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna"},{"key":"4590_CR19","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.2337\/diacare.26.12.3230","volume":"26","author":"J Lindstr\u00f6m","year":"2003","unstructured":"Lindstr\u00f6m J, Louheranta A, Mannelin M et al (2003) The Finnish diabetes prevention study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26:3230\u20133236","journal-title":"Diabetes Care"},{"key":"4590_CR20","doi-asserted-by":"publisher","first-page":"e74341","DOI":"10.1371\/journal.pone.0074341","volume":"8","author":"PJ Meikle","year":"2013","unstructured":"Meikle PJ, Wong G, Barlow CK et al (2013) Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One 8:e74341","journal-title":"PLoS One"},{"key":"4590_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2337\/db08-1228","volume":"58","author":"JM Haus","year":"2009","unstructured":"Haus JM, Kashyap SR, Kasumov T et al (2009) Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58:337\u2013343","journal-title":"Diabetes"},{"key":"4590_CR22","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.2337\/db06-0330","volume":"55","author":"F Samad","year":"2006","unstructured":"Samad F, Hester KD, Yang G, Hannun YA, Bielawski J (2006) Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55:2579\u20132587","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"4590_CR23","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.2337\/dc09-S302","volume":"32","author":"RA DeFronzo","year":"2009","unstructured":"DeFronzo RA, Tripathy D (2009) Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32(Suppl 2):S157\u2013S163","journal-title":"Diabetes Care"},{"key":"4590_CR24","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/oby.21448","volume":"24","author":"KT Tonks","year":"2016","unstructured":"Tonks KT, Coster AC, Christopher MJ et al (2016) Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight\/obesity in humans. Obesity (Silver Spring) 24:908\u2013916","journal-title":"Obesity (Silver Spring)"},{"key":"4590_CR25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00125-015-3850-y","volume":"59","author":"BC Bergman","year":"2016","unstructured":"Bergman BC, Brozinick JT, Strauss A et al (2016) Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans. Diabetologia 59:785\u2013798","journal-title":"Diabetologia"},{"key":"4590_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2337\/diabetes.53.1.25","volume":"53","author":"JM Adams","year":"2004","unstructured":"Adams JM, Pratipanawatr T, Berria R et al (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53:25\u201331","journal-title":"Diabetes"},{"key":"4590_CR27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","volume":"20","author":"SM Turpin","year":"2014","unstructured":"Turpin SM, Nicholls HT, Willmes DM et al (2014) Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab 20:678\u2013686","journal-title":"Cell Metab"},{"key":"4590_CR28","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1007\/s00125-013-2913-1","volume":"56","author":"N Turner","year":"2013","unstructured":"Turner N, Kowalski GM, Leslie SJ et al (2013) Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 56:1638\u20131648","journal-title":"Diabetologia"},{"key":"4590_CR29","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/eurheartj\/ehx205","volume":"38","author":"M Nicholls","year":"2017","unstructured":"Nicholls M (2017) Plasma ceramides and cardiac risk. Eur Heart J 38:1359\u20131360","journal-title":"Eur Heart J"},{"key":"4590_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino","year":"2008","unstructured":"D\u2019Agostino RB, Vasan RS, Pencina MJ et al (2008) General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 117:743\u2013753","journal-title":"Circulation"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-018-4590-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4590-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4590-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T20:12:30Z","timestamp":1552594350000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-018-4590-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4590"],"URL":"https:\/\/doi.org\/10.1007\/s00125-018-4590-6","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"31 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Zora Biosciences Oy holds patents for the diagnostic use of ceramides for cardiovascular risk determination. MH and DK are employees, and RL is an employee and shareholder, of Zora Biosciences Oy. VS participated in a congress trip sponsored by Novo Nordisk.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}